Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Is discussion of colorectal cancer screening options associated with heightened patient confusion?

Jones RM, Vernon SW, Woolf SH.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2821-5. doi: 10.1158/1055-9965.EPI-10-0695. Epub 2010 Sep 17.

2.

A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, Cordes JE, Engelhard D.

J Natl Cancer Inst. 2004 May 19;96(10):770-80.

3.

Colorectal cancer screening adherence in a general population.

Yeazel MW, Church TR, Jones RM, Kochevar LK, Watt GD, Cordes JE, Engelhard D, Mongin SJ.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):654-7. Erratum in: Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1550.

4.

The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial.

Griffith JM, Lewis CL, Brenner AR, Pignone MP.

BMC Med Inform Decis Mak. 2008 Jan 24;8:4. doi: 10.1186/1472-6947-8-4.

5.

Colorectal cancer screening among Mexican Americans at a community clinic.

Yepes-Rios M, Reimann JO, Talavera AC, Ruiz de Esparza A, Talavera GA.

Am J Prev Med. 2006 Mar;30(3):204-10.

PMID:
16476635
6.

Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C; SCORE Working Group.

J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22. doi: 10.1093/jnci/djr284. Epub 2011 Aug 18. Erratum in: J Natl Cancer Inst. 2011 Dec 21;103(24):1903. Fracchia, M [added].

7.

Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.

Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, Halek K, Griffin JM, van Ryn M, Fisher DA.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):768-76. doi: 10.1158/1055-9965.EPI-07-0759. Epub 2008 Apr 1.

8.

Patient preferences for colorectal cancer screening.

Leard LE, Savides TJ, Ganiats TG.

J Fam Pract. 1997 Sep;45(3):211-8.

PMID:
9300000
9.

Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.

Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):777-84. doi: 10.1158/1055-9965.EPI-07-0441. Epub 2008 Apr 1.

10.

Predictors of compliance with free endoscopic colorectal cancer screening in uninsured adults.

Anderson JC, Fortinsky RH, Kleppinger A, Merz-Beyus AB, Huntington CG 3rd, Lagarde S.

J Gen Intern Med. 2011 Aug;26(8):875-80. doi: 10.1007/s11606-011-1716-7. Epub 2011 Apr 16.

11.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
12.

A case-control study to evaluate efficacy of screening for faecal occult blood.

Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH.

J Med Screen. 1995;2(2):84-9.

PMID:
7497161
13.

Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.

Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, Castiglione G, Grazzini G, Taddei S, Gasperoni S, Giuliani O, Malfitana G, Marutti A, Genta G, Segnan N.

Am J Gastroenterol. 2010 Jan;105(1):188-98. doi: 10.1038/ajg.2009.583. Epub 2009 Oct 13.

PMID:
19826409
14.

Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.

Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S.

Med Care. 2008 Sep;46(9 Suppl 1):S10-6. doi: 10.1097/MLR.0b013e31817d932e.

PMID:
18725820
15.

Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.

Mack LA, Cook LS, Temple WJ, Carlson LE, Hilsden RJ, Paolucci EO.

Ann Surg Oncol. 2009 Aug;16(8):2092-100. doi: 10.1245/s10434-009-0528-z. Epub 2009 May 29.

PMID:
19479307
16.

Individual- and provider-level factors associated with colorectal cancer screening in accordance with guideline recommendation: a community-level perspective across varying levels of risk.

Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia J, McEvoy M.

BMC Public Health. 2013 Mar 20;13:248. doi: 10.1186/1471-2458-13-248.

17.

The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.

El-Serag HB, Petersen L, Hampel H, Richardson P, Cooper G.

Arch Intern Med. 2006 Nov 13;166(20):2202-8.

PMID:
17101937
18.

Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines.

Erban S, Zapka J, Puleo E, Vickers-Lahti M.

Eff Clin Pract. 2001 Jan-Feb;4(1):10-7.

PMID:
11234181
19.

Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.

Carlos RC, Fendrick AM, Abrahamse PH, Dong Q, Patterson SK, Bernstein SJ.

Womens Health Issues. 2005 Nov-Dec;15(6):249-57.

PMID:
16325138
20.

Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.

Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG.

J Natl Cancer Inst. 1993 Aug 18;85(16):1311-8.

PMID:
8340943
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk